MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kenvue Inc. Common Stock (NY:KVUE)

17.84 +0.07 (+0.42%)
Delayed Quote Updated: 10:02 AM EDT, Oct 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Kenvue Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
30 31 Next >
What's going on in today's session: S&P500 most active stocks ↗
Via Chartmill
News headline image
2 Dividend Stocks Worth Holding Forever (Including 1 Dividend King) ↗
A 50-year dividend grower and a monthly income REIT; how J&J and Realty Income build lasting wealth for patient investors. 
Via The Motley Fool
News headline image
3 Dividend Stocks to Buy in October and Hold for 20 Years ↗
These three dividend payers are making bold, sometimes expensive moves right now, bets I think will pay off for investors willing to hold for the next 20 years. 
Via The Motley Fool
News headline image
History Says Johnson & Johnson Beats Medtronic. Here's Why I'd Still Consider MDT for the Next Decade. ↗
Medtronic is following a strategy that has worked well for Johnson & Johnson. 
Via The Motley Fool
In today's session, there are S&P500 stocks with remarkable trading volume. ↗
Via Chartmill
Kenvue (NYSE:KVUE) Falls After Q2 Earnings Miss as Kimberly-Clark Deal Looms ↗
Via Chartmill
Topics Earnings
News headline image
LISTERINE® Launches Oral Care Counts This World Smile Day as Oral Disease Cases Rise to 3.73 Billion
From Kenvue
Via Business Wire
News headline image
Neutrogena®, Aveeno®, and Regaine® Present New Scientific Evidence Demonstrating How Science-Backed Ingredients Support Healthy Skin and Hair
From Kenvue
Via Business Wire
News headline image
Johnson & Johnson May Offload Its Orthopedics Unit for $20 Billion -- and Investors Shouldn't Miss What That Could Signal ↗
Healthcare giant Johnson & Johnson is looking to become a more profitable and faster-growing business. 
Via The Motley Fool
News headline image
Better Dividend King to Buy and Hold: Johnson & Johnson or Kenvue? ↗
One healthcare dividend payer carries legal risk, the other faces a buyout. Here's which one actually deserves your money. 
Via The Motley Fool
Explore the S&P500 index on Tuesday and find out which stocks are the most active in today's session. ↗
Via Chartmill
These S&P500 stocks are the most active in today's session ↗
Via Chartmill
News headline image
Here's My Pick for the Smartest High-Yield Dividend Stock to Buy Right Now ↗
Kenvue's dependable dividend is above average, and it could go even higher if the company is bought by Kimberly-Clark. 
Via The Motley Fool
News headline image
Kimberly Clark is Down 20% From Its 52-Week High. Is the Dip Worth Buying? ↗
Kimberly Clark is a consumer staples Dividend King with a 5% yield, but it is also undergoing a major business transition. 
Via The Motley Fool
Curious about the most active S&P500 stocks in today's session? ↗
Via Chartmill
Curious about the most active S&P500 stocks in today's session? ↗
Via Chartmill
News headline image
Kenvue Declares Quarterly Cash Dividend
From Kenvue
Via Business Wire
News headline image
This Dividend King Just Offered a Buy-the-Dip Opportunity ↗
Deal skepticism and litigation fears still weigh on this consumer staples stalwart. 
Via The Motley Fool
Topics Lawsuit
News headline image
Warren Buffett Thinks Investors Are "Gambling" Right Now. Here are 2 Stocks That Should Be Safe Bets. ↗
Johnson & Johnson and Merck are healthcare giants with dependable returns that weather economic downturns well. 
Via The Motley Fool
Topics Economy
Explore the S&P500 index on Wednesday and find out which stocks are the most active in today's session. ↗
Via Chartmill
News headline image
This Consumer Staples Giant's Dividend Streak Rivals PepsiCo. Nobody Talks About It. ↗
Kimberly Clark is a lesser-known Dividend King. 
Via The Motley Fool
News headline image
2 Dividend Stocks to Buy and Never Sell ↗
Both of these healthcare leaders are Dividend Kings. 
Via The Motley Fool
Topics Economy
News headline image
Johnson & Johnson Just Sent Shareholders an Important 11-Word Message About Its Future ↗
Johnson & Johnson's new drugs may offset declining sales due to patent-protection losses. 
Via The Motley Fool
Topics Earnings Intellectual Property
News headline image
Kimberly-Clark (KMB) Q2 2026 Earnings Call Transcript ↗
Hsu discusses tariff refunds, China disruptions, and Kenvue integration plans. 
Via The Motley Fool
Topics Earnings World Trade
News headline image
Kenvue Reports Second Quarter 2026 Results
From Kenvue
Via Business Wire
News headline image
3 Dividend Stocks That Are No-Brainer Buys for the Second Half of 2026 ↗
As stocks pull back from recent highs, lean into these three blue chip dividend stocks. 
Via The Motley Fool
News headline image
Kenvue Increases Quarterly Cash Dividend
From Kenvue
Via Business Wire
News headline image
This "Boring" Dividend King Is Quietly Turning Into a Growth Machine -- and Many Investors Are Missing It ↗
A name that's often ignored by investors due to its limited historic growth is evolving into a solid income-growth prospect. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Kenvue to Announce Second Quarter 2026 Results on August 6, 2026
From Kenvue
Via Business Wire
News headline image
An Overlooked Dividend King With a 54-Year Winning Streak Worth Buying Now ↗
This Dividend King just made a major strategic pivot. 
Via The Motley Fool
Topics Supply Chain
< Previous 1 2 3 4 5 6 7 8 9
...
30 31 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story